PL2067781T3 - Pirolochinolinochinon do poprawy stanu w przypadku insulinooporności - Google Patents

Pirolochinolinochinon do poprawy stanu w przypadku insulinooporności

Info

Publication number
PL2067781T3
PL2067781T3 PL07807502T PL07807502T PL2067781T3 PL 2067781 T3 PL2067781 T3 PL 2067781T3 PL 07807502 T PL07807502 T PL 07807502T PL 07807502 T PL07807502 T PL 07807502T PL 2067781 T3 PL2067781 T3 PL 2067781T3
Authority
PL
Poland
Prior art keywords
insulin resistance
pyrroloquinoline quinone
improving insulin
improving
pyrroloquinoline
Prior art date
Application number
PL07807502T
Other languages
English (en)
Inventor
Mika Sumi
Fumiko Ogino
Toshikazu Kamiya
Masahiko Nakano
Kazutoshi Kikkawa
Original Assignee
Mitsubishi Gas Chemical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Gas Chemical Co filed Critical Mitsubishi Gas Chemical Co
Publication of PL2067781T3 publication Critical patent/PL2067781T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
    • A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
    • A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
    • A23G3/364—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G4/00—Chewing gum
    • A23G4/06—Chewing gum characterised by the composition containing organic or inorganic compounds
    • A23G4/12—Chewing gum characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/328—Foods, ingredients or supplements having a functional effect on health having effect on glycaemic control and diabetes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Inorganic Chemistry (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PL07807502T 2006-09-19 2007-09-19 Pirolochinolinochinon do poprawy stanu w przypadku insulinooporności PL2067781T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2006253265 2006-09-19
PCT/JP2007/068114 WO2008035686A1 (fr) 2006-09-19 2007-09-19 Agent pour améliorer la résistance à l'insuline
EP07807502.5A EP2067781B1 (en) 2006-09-19 2007-09-19 Pyrroloquinoline quinone for improving insulin resistance

Publications (1)

Publication Number Publication Date
PL2067781T3 true PL2067781T3 (pl) 2013-12-31

Family

ID=39200511

Family Applications (1)

Application Number Title Priority Date Filing Date
PL07807502T PL2067781T3 (pl) 2006-09-19 2007-09-19 Pirolochinolinochinon do poprawy stanu w przypadku insulinooporności

Country Status (7)

Country Link
US (1) US8097635B2 (pl)
EP (1) EP2067781B1 (pl)
JP (1) JPWO2008035686A1 (pl)
CN (1) CN101578284B (pl)
CA (1) CA2666649A1 (pl)
PL (1) PL2067781T3 (pl)
WO (1) WO2008035686A1 (pl)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5392089B2 (ja) * 2007-11-14 2014-01-22 三菱瓦斯化学株式会社 皮膚の乾癬予防または改善剤
CA2779539A1 (en) * 2009-11-06 2011-05-12 Kazuto Ikemoto Pyrroloquinoline quinone in free form
EP2567959B1 (en) 2011-09-12 2014-04-16 Sanofi 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
CN103191115B (zh) * 2013-03-29 2015-09-09 上海医学生命科学研究中心有限公司 吡咯并喹啉醌在制备用于治疗和/或改善糖尿病足的药物中的应用
JP2015131823A (ja) * 2015-02-23 2015-07-23 株式会社ディーエイチシー Ｉｉ型糖尿病治療薬、及び育毛剤
CN107007606B (zh) * 2016-02-04 2021-10-26 南京舒鹏生物科技有限公司 一种用于干燥综合症预防及治疗的药物及其组合
JP2017175966A (ja) * 2016-03-29 2017-10-05 三菱瓦斯化学株式会社 ピロロキノリンキノン含有紅茶風飲料
US20200375211A1 (en) * 2017-10-25 2020-12-03 Mitsubishi Gas Chemical Company, Inc. Tea flavor improving agent and packaged tea beverage comprising same
JPWO2019082550A1 (ja) * 2017-10-25 2020-11-12 三菱瓦斯化学株式会社 ピロロキノリンキノン含有グミキャンディ及びその製造方法
CN108079000A (zh) * 2018-02-01 2018-05-29 湖南博隽生物医药有限公司 一种治疗糖尿病的药物组合物及其制备方法
US11185565B2 (en) * 2019-01-02 2021-11-30 Gm Pharmaceuticals, Inc. Compositions including milk thistle and methods of use

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6158584A (ja) 1984-08-30 1986-03-25 Ube Ind Ltd 細胞増殖促進剤及び細胞増殖促進方法
CA1302275C (en) * 1986-08-07 1992-06-02 Yuji Narutomi Enzyme inhibitor
JPS6348215A (ja) 1986-08-14 1988-02-29 Sogo Yatsukou Kk 糖尿病性合併症治療剤
JPH085791B2 (ja) 1986-08-07 1996-01-24 相互薬工株式会社 抗白内障剤
JPH085792B2 (ja) 1986-12-19 1996-01-24 相互薬工株式会社 逆転写酵素阻害剤
JP2751183B2 (ja) 1988-02-26 1998-05-18 三菱瓦斯化学株式会社 ピロロキノリンキノンの製造方法
JPH03123781A (ja) 1989-10-09 1991-05-27 Mitsubishi Gas Chem Co Inc ピロロキノリンキノンエステル
JPH03145492A (ja) 1989-10-30 1991-06-20 Mitsubishi Gas Chem Co Inc ピロロキノリンキノンエステル
JPH04198128A (ja) 1990-11-28 1992-07-17 Mitsubishi Gas Chem Co Inc 糖尿病性合併症治療剤
JPH0578247A (ja) 1991-03-04 1993-03-30 Mitsubishi Gas Chem Co Inc 活性酸素消去剤
US5369112A (en) 1991-03-04 1994-11-29 Mitsubishi Gas Chemical Company, Inc. Method of treating cataracts caused by active oxygen
JPH06211660A (ja) 1992-02-07 1994-08-02 Sagami Chem Res Center 神経成長因子産生促進剤
JPH06256191A (ja) 1993-03-09 1994-09-13 Mitsubishi Gas Chem Co Inc 糖尿病性合併症治療剤
JPH0820512A (ja) 1994-07-07 1996-01-23 Mitsubishi Gas Chem Co Inc メラニン産生抑制剤及び美白用皮膚外用剤
JP3625493B2 (ja) 1994-07-07 2005-03-02 三菱瓦斯化学株式会社 紫外線吸収剤及び皮膚外用剤
JPH1025292A (ja) 1996-07-10 1998-01-27 Mitsubishi Gas Chem Co Inc 新規なピロロキノリンキノン化合物
JP4777489B2 (ja) 1997-03-31 2011-09-21 ザ チルドレンズ メディカル センター コーポレーション アポトーシス性酵素を不活性化するためのニトロシル化
US7241461B2 (en) * 2004-03-23 2007-07-10 Lifeline Nutraceuticals Corporation Compositions for alleviating inflammation and oxidative stress in a mammal
RU2007111720A (ru) * 2004-08-30 2008-10-10 Канека Корпорейшн (Jp) Активаторы митохондрий
JP2006253265A (ja) 2005-03-09 2006-09-21 Sony Corp 半導体装置の製造方法
WO2007105730A1 (ja) * 2006-03-13 2007-09-20 Kyowa Hakko Kogyo Co., Ltd. インスリン抵抗性改善剤
EP2068879A2 (en) 2006-05-02 2009-06-17 Medical Technology Acceleration Program, Inc. Pyrroloquinoline quinone drugs and methods of use thereof

Also Published As

Publication number Publication date
JPWO2008035686A1 (ja) 2010-01-28
US20100093780A1 (en) 2010-04-15
CN101578284A (zh) 2009-11-11
CN101578284B (zh) 2012-08-15
CA2666649A1 (en) 2008-03-27
WO2008035686A1 (fr) 2008-03-27
EP2067781B1 (en) 2013-07-24
EP2067781A1 (en) 2009-06-10
US8097635B2 (en) 2012-01-17
EP2067781A4 (en) 2009-12-02

Similar Documents

Publication Publication Date Title
PL2067781T3 (pl) Pirolochinolinochinon do poprawy stanu w przypadku insulinooporności
GB2445090B (en) Improved autoinjector
GB2434317B (en) Improved autoinjector
GB2436526B (en) Syringe
HUP0900122A3 (en) Capsule with reduced dripping
PL2452709T3 (pl) Kaniula
GB0600022D0 (en) Glazings
GB2460685B (en) An inclusive chair
HK1120806A1 (en) Agent for improving insulin resistance
EP2015810A4 (en) IMPROVED SYRINGE
GB0608046D0 (en) Syringe
EP2035031A4 (en) INSULIN COMPOSITION
TWI372862B (en) Reference electrode
GB0610596D0 (en) Electrode
HK1125441A1 (en) Purge tee assembly
AU316472S (en) Cannula
GB2434252B (en) Component Current Measuring Arrangement
GB0617345D0 (en) Rack
GB0704573D0 (en) Multi-use retaining means
EP2191261A4 (en) ELECTRODE
ZA200808100B (en) Insulin derivative
GB0611174D0 (en) Improved rack
AU2008903707A0 (en) Resistance Meter
GB0623490D0 (en) Electrode
PL380534A1 (pl) Elektroda odniesienia